

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 6.02886550 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 6.02886550 |
| 3 | desmosome organization (GO:0002934) | 5.75900463 |
| 4 | endocrine pancreas development (GO:0031018) | 5.25471269 |
| 5 | * intestinal absorption (GO:0050892) | 4.85973534 |
| 6 | intestinal epithelial cell development (GO:0060576) | 4.75381048 |
| 7 | peptide hormone processing (GO:0016486) | 4.72257365 |
| 8 | hemidesmosome assembly (GO:0031581) | 4.68801339 |
| 9 | intestinal cholesterol absorption (GO:0030299) | 4.55727522 |
| 10 | drug transmembrane transport (GO:0006855) | 4.51974823 |
| 11 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 4.50111305 |
| 12 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.40747559 |
| 13 | COPII vesicle coating (GO:0048208) | 4.39362037 |
| 14 | glandular epithelial cell differentiation (GO:0002067) | 4.37323669 |
| 15 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.32033230 |
| 16 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.25655423 |
| 17 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.25655423 |
| 18 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.09239416 |
| 19 | regulation of water loss via skin (GO:0033561) | 4.07417510 |
| 20 | protein retention in ER lumen (GO:0006621) | 4.06301672 |
| 21 | hormone catabolic process (GO:0042447) | 4.00994055 |
| 22 | signal peptide processing (GO:0006465) | 3.85276571 |
| 23 | drug transport (GO:0015893) | 3.75443744 |
| 24 | keratinocyte proliferation (GO:0043616) | 3.73045291 |
| 25 | establishment of skin barrier (GO:0061436) | 3.71995779 |
| 26 | columnar/cuboidal epithelial cell development (GO:0002066) | 3.71177579 |
| 27 | renal absorption (GO:0070293) | 3.69947094 |
| 28 | multicellular organismal water homeostasis (GO:0050891) | 3.69436537 |
| 29 | angiotensin maturation (GO:0002003) | 3.60821557 |
| 30 | peptide catabolic process (GO:0043171) | 3.58559522 |
| 31 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.56948341 |
| 32 | glycosphingolipid catabolic process (GO:0046479) | 3.51987713 |
| 33 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.51940512 |
| 34 | response to hepatocyte growth factor (GO:0035728) | 3.50212096 |
| 35 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.50212096 |
| 36 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.48724556 |
| 37 | * cellular response to vitamin D (GO:0071305) | 3.47751097 |
| 38 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.44100416 |
| 39 | neutrophil activation involved in immune response (GO:0002283) | 3.43288796 |
| 40 | response to peptidoglycan (GO:0032494) | 3.36685790 |
| 41 | type B pancreatic cell development (GO:0003323) | 3.33023903 |
| 42 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.32047395 |
| 43 | urate metabolic process (GO:0046415) | 3.31721680 |
| 44 | cytidine metabolic process (GO:0046087) | 3.27712128 |
| 45 | cytidine catabolic process (GO:0006216) | 3.27712128 |
| 46 | cytidine deamination (GO:0009972) | 3.27712128 |
| 47 | glycolipid catabolic process (GO:0019377) | 3.26736687 |
| 48 | flavonoid metabolic process (GO:0009812) | 3.26027795 |
| 49 | sequestering of metal ion (GO:0051238) | 3.24076687 |
| 50 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.23705076 |
| 51 | drug catabolic process (GO:0042737) | 3.22125220 |
| 52 | * regulation of vitamin metabolic process (GO:0030656) | 3.20021248 |
| 53 | glandular epithelial cell development (GO:0002068) | 3.18782221 |
| 54 | vitamin A metabolic process (GO:0006776) | 3.17848051 |
| 55 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.16805374 |
| 56 | phospholipid scrambling (GO:0017121) | 3.16199936 |
| 57 | adhesion of symbiont to host cell (GO:0044650) | 3.15184697 |
| 58 | virion attachment to host cell (GO:0019062) | 3.15184697 |
| 59 | diol metabolic process (GO:0034311) | 3.14534918 |
| 60 | adhesion of symbiont to host (GO:0044406) | 3.11340433 |
| 61 | negative regulation of interleukin-12 production (GO:0032695) | 3.07090701 |
| 62 | regulation of cellular extravasation (GO:0002691) | 3.04579394 |
| 63 | organic cation transport (GO:0015695) | 3.02906337 |
| 64 | protein maturation by protein folding (GO:0022417) | 3.02806399 |
| 65 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.00979272 |
| 66 | exocrine pancreas development (GO:0031017) | 3.00955544 |
| 67 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.00216498 |
| 68 | detection of other organism (GO:0098543) | 2.98232936 |
| 69 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.97559569 |
| 70 | positive regulation of nuclease activity (GO:0032075) | 2.96417205 |
| 71 | macrophage activation involved in immune response (GO:0002281) | 2.95847277 |
| 72 | ceramide catabolic process (GO:0046514) | 2.95604134 |
| 73 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.95232456 |
| 74 | molting cycle (GO:0042303) | 2.93812448 |
| 75 | hair cycle (GO:0042633) | 2.93812448 |
| 76 | growth hormone receptor signaling pathway (GO:0060396) | 2.92753174 |
| 77 | regulation of cholesterol homeostasis (GO:2000188) | 2.90155348 |
| 78 | detection of bacterium (GO:0016045) | 2.89685395 |
| 79 | regulation of podosome assembly (GO:0071801) | 2.89145878 |
| 80 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.87885471 |
| 81 | modulation by symbiont of host immune response (GO:0052553) | 2.87885471 |
| 82 | positive regulation by symbiont of host defense response (GO:0052509) | 2.87885471 |
| 83 | modulation by symbiont of host defense response (GO:0052031) | 2.87885471 |
| 84 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.87885471 |
| 85 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.87885471 |
| 86 | positive regulation of p38MAPK cascade (GO:1900745) | 2.87798688 |
| 87 | NIK/NF-kappaB signaling (GO:0038061) | 2.87757643 |
| 88 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.86504082 |
| 89 | * digestive system process (GO:0022600) | 2.86172847 |
| 90 | immunoglobulin mediated immune response (GO:0016064) | 2.85546533 |
| 91 | positive regulation of insulin secretion (GO:0032024) | 2.85148280 |
| 92 | water homeostasis (GO:0030104) | 2.84354135 |
| 93 | excretion (GO:0007588) | 2.83852218 |
| 94 | GDP-mannose metabolic process (GO:0019673) | 2.83272179 |
| 95 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.82264691 |
| 96 | phosphate ion transport (GO:0006817) | 2.81938666 |
| 97 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.81808096 |
| 98 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.79511925 |
| 99 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.78292207 |
| 100 | * negative regulation of keratinocyte proliferation (GO:0010839) | 2.78071085 |
| 101 | O-glycan processing (GO:0016266) | 2.77586596 |
| 102 | transcytosis (GO:0045056) | 2.73771416 |
| 103 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.73083552 |
| 104 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.71911366 |
| 105 | membrane lipid catabolic process (GO:0046466) | 2.69841047 |
| 106 | transepithelial transport (GO:0070633) | 2.69490198 |
| 107 | regulation of integrin activation (GO:0033623) | 2.68844192 |
| 108 | sphingolipid catabolic process (GO:0030149) | 2.68720263 |
| 109 | sulfur compound transport (GO:0072348) | 2.66951428 |
| 110 | regulation of mononuclear cell migration (GO:0071675) | 2.66780360 |
| 111 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.66341365 |
| 112 | regulation of nuclease activity (GO:0032069) | 2.66096936 |
| 113 | digestion (GO:0007586) | 2.65356640 |
| 114 | * cellular response to vitamin (GO:0071295) | 2.64899276 |
| 115 | eosinophil chemotaxis (GO:0048245) | 2.63666777 |
| 116 | tricarboxylic acid metabolic process (GO:0072350) | 2.61562344 |
| 117 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.61313312 |
| 118 | membrane repolarization during action potential (GO:0086011) | 2.60767496 |
| 119 | sphingoid metabolic process (GO:0046519) | 2.60277972 |
| 120 | vesicle coating (GO:0006901) | 2.59489220 |
| 121 | oligosaccharide catabolic process (GO:0009313) | 2.59266857 |
| 122 | cellular extravasation (GO:0045123) | 2.59225221 |
| 123 | granulocyte activation (GO:0036230) | 2.58401979 |
| 124 | modified amino acid transport (GO:0072337) | 2.57830563 |
| 125 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.57488745 |
| 126 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.56691708 |
| 127 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.56625469 |
| 128 | regulation of antigen processing and presentation (GO:0002577) | 2.55716794 |
| 129 | dendritic cell chemotaxis (GO:0002407) | 2.55400755 |
| 130 | protein localization to endosome (GO:0036010) | 2.54882472 |
| 131 | nucleotide-sugar metabolic process (GO:0009225) | 2.54825940 |
| 132 | negative regulation of cell killing (GO:0031342) | 2.54581144 |
| 133 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.54581144 |
| 134 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.54251787 |
| 135 | neutrophil activation (GO:0042119) | 2.53853140 |
| 136 | sphingosine metabolic process (GO:0006670) | 2.53820844 |
| 137 | fucose metabolic process (GO:0006004) | 2.53804831 |
| 138 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.53741563 |
| 139 | detection of external biotic stimulus (GO:0098581) | 2.51592295 |
| 140 | toxin metabolic process (GO:0009404) | 2.51329431 |
| 141 | cellular response to unfolded protein (GO:0034620) | 2.51310583 |
| 142 | glycoside metabolic process (GO:0016137) | 2.50975622 |
| 143 | positive regulation of antigen processing and presentation (GO:0002579) | 2.50634100 |
| 144 | * regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.50492451 |
| 145 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.49998817 |
| 146 | gland morphogenesis (GO:0022612) | 2.47685052 |
| 147 | germinal center formation (GO:0002467) | 2.47684064 |
| 148 | keratinization (GO:0031424) | 2.47626035 |
| 149 | cellular response to growth hormone stimulus (GO:0071378) | 2.47254591 |
| 150 | T-helper 1 type immune response (GO:0042088) | 2.46976022 |
| 151 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.46392195 |
| 152 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.46295830 |
| 153 | positive regulation of leukocyte degranulation (GO:0043302) | 2.46187816 |
| 154 | regulation of monocyte chemotaxis (GO:0090025) | 2.45141482 |
| 155 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.43896387 |
| 156 | * regulation of vitamin D biosynthetic process (GO:0060556) | 2.41741136 |
| 157 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.41358154 |
| 158 | interferon-gamma secretion (GO:0072643) | 2.40069264 |
| 159 | regulation of leukocyte degranulation (GO:0043300) | 2.37712699 |
| 160 | regulation of mast cell degranulation (GO:0043304) | 2.37698561 |
| 161 | skin morphogenesis (GO:0043589) | 2.36548482 |
| 162 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.35921814 |
| 163 | response to type I interferon (GO:0034340) | 2.32863153 |
| 164 | eosinophil migration (GO:0072677) | 2.32297828 |
| 165 | cellular response to type I interferon (GO:0071357) | 2.31957523 |
| 166 | type I interferon signaling pathway (GO:0060337) | 2.31957523 |
| 167 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.31826971 |
| 168 | detection of molecule of bacterial origin (GO:0032490) | 2.30543785 |
| 169 | dendritic cell migration (GO:0036336) | 2.30363446 |
| 170 | positive regulation of type 2 immune response (GO:0002830) | 2.29914105 |
| 171 | regulation of extracellular matrix disassembly (GO:0010715) | 2.27897429 |
| 172 | barbed-end actin filament capping (GO:0051016) | 2.27793251 |
| 173 | regulation of gamma-delta T cell activation (GO:0046643) | 2.26957225 |
| 174 | myeloid dendritic cell differentiation (GO:0043011) | 2.24164709 |
| 175 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.20934663 |
| 176 | regulation of regulatory T cell differentiation (GO:0045589) | 2.18293024 |
| 177 | regulation of macrophage chemotaxis (GO:0010758) | 2.17978836 |
| 178 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.16748653 |
| 179 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.16420716 |
| 180 | detection of biotic stimulus (GO:0009595) | 2.15524932 |
| 181 | regulation of guanylate cyclase activity (GO:0031282) | 2.14976442 |
| 182 | mannose metabolic process (GO:0006013) | 2.14541531 |
| 183 | pinocytosis (GO:0006907) | 2.13416918 |
| 184 | defense response to protozoan (GO:0042832) | 2.13277027 |
| 185 | thrombin receptor signaling pathway (GO:0070493) | 2.12479162 |
| 186 | regulation of chemokine biosynthetic process (GO:0045073) | 2.11878774 |
| 187 | response to protozoan (GO:0001562) | 2.10460458 |
| 188 | positive regulation of mast cell activation (GO:0033005) | 2.10456509 |
| 189 | regulation of viral release from host cell (GO:1902186) | 2.10324180 |
| 190 | cyclooxygenase pathway (GO:0019371) | 2.10104156 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * TP63_17297297_ChIP-ChIP_HaCaT_Human | 9.01944864 |
| 2 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.62731499 |
| 3 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.45820548 |
| 4 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.34782139 |
| 5 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.19848349 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.11099077 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.93233511 |
| 8 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.88803180 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.80340166 |
| 10 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.65659141 |
| 11 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.62125014 |
| 12 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.59284226 |
| 13 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.59211572 |
| 14 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.45804739 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.37244124 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.36063794 |
| 17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.35592308 |
| 18 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.31472028 |
| 19 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.30607581 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.28222503 |
| 21 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.28132883 |
| 22 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 2.22881003 |
| 23 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 2.21672417 |
| 24 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.18845635 |
| 25 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 2.16611557 |
| 26 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.13288575 |
| 27 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.09973483 |
| 28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.02844973 |
| 29 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.96240391 |
| 30 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.92851252 |
| 31 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.92655049 |
| 32 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.85244672 |
| 33 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.84617448 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.83113822 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.79058371 |
| 36 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.75602245 |
| 37 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.72605218 |
| 38 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.71767893 |
| 39 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.69279800 |
| 40 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.69045558 |
| 41 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.66856272 |
| 42 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.66131879 |
| 43 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.65755981 |
| 44 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.64037911 |
| 45 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.63528581 |
| 46 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.63320539 |
| 47 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.60263933 |
| 48 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.57523209 |
| 49 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.56888289 |
| 50 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.55717404 |
| 51 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.55438106 |
| 52 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.54069331 |
| 53 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53206158 |
| 54 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.53177088 |
| 55 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.50533129 |
| 56 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.50280202 |
| 57 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.50131851 |
| 58 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.49546363 |
| 59 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.46656982 |
| 60 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.46214692 |
| 61 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.45928844 |
| 62 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44847733 |
| 63 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.44633970 |
| 64 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.43906709 |
| 65 | ATF3_27146783_Chip-Seq_COLON_Human | 1.42523425 |
| 66 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.41833021 |
| 67 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.41006568 |
| 68 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.41006568 |
| 69 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.39640622 |
| 70 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.38128414 |
| 71 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38100077 |
| 72 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.37186223 |
| 73 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.35932296 |
| 74 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.33953815 |
| 75 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.33583726 |
| 76 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.33546504 |
| 77 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.32034213 |
| 78 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.31876109 |
| 79 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29500684 |
| 80 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.28190604 |
| 81 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.27789936 |
| 82 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.27142588 |
| 83 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.26770928 |
| 84 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25374508 |
| 85 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.25288536 |
| 86 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.24784223 |
| 87 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.23223426 |
| 88 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.22150430 |
| 89 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.20953589 |
| 90 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.18106483 |
| 91 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.17163164 |
| 92 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.17163164 |
| 93 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.17163164 |
| 94 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.17093949 |
| 95 | GATA1_19941826_ChIP-Seq_K562_Human | 1.16920158 |
| 96 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.16156340 |
| 97 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15951933 |
| 98 | * MAF_26560356_Chip-Seq_TH1_Human | 1.15166502 |
| 99 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.12675389 |
| 100 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11908333 |
| 101 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11189356 |
| 102 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.09568332 |
| 103 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.08183503 |
| 104 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.08158359 |
| 105 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08101032 |
| 106 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.06141800 |
| 107 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05603061 |
| 108 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.05283216 |
| 109 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.04037852 |
| 110 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03303793 |
| 111 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02847687 |
| 112 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.02718953 |
| 113 | MYB_26560356_Chip-Seq_TH2_Human | 1.02400131 |
| 114 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.02242909 |
| 115 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01916605 |
| 116 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00286682 |
| 117 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.00070333 |
| 118 | CJUN_26792858_Chip-Seq_BT549_Human | 0.99229764 |
| 119 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98232299 |
| 120 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.97412469 |
| 121 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.96458603 |
| 122 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95724275 |
| 123 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.95519790 |
| 124 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95509663 |
| 125 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.92016384 |
| 126 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.91892566 |
| 127 | RXR_22108803_ChIP-Seq_LS180_Human | 0.89235606 |
| 128 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.87420822 |
| 129 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.86191223 |
| 130 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.85142115 |
| 131 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.84385104 |
| 132 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82513635 |
| 133 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.82496272 |
| 134 | GATA2_19941826_ChIP-Seq_K562_Human | 0.79598613 |
| 135 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.79162244 |
| 136 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.79069659 |
| 137 | VDR_22108803_ChIP-Seq_LS180_Human | 0.78517884 |
| 138 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.78206005 |
| 139 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.77882118 |
| 140 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.77297213 |
| 141 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.77297213 |
| 142 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.75021646 |
| 143 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.74789987 |
| 144 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.72862470 |
| 145 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.72813981 |
| 146 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.71005792 |
| 147 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.70300077 |
| 148 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.69642977 |
| 149 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.69049214 |
| 150 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.68854578 |
| 151 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.68538624 |
| 152 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.67812167 |
| 153 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.67016915 |
| 154 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.66951166 |
| 155 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.66391719 |
| 156 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.66156731 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004043_abnormal_pH_regulation | 4.39648003 |
| 2 | MP0002877_abnormal_melanocyte_morpholog | 3.97915101 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 3.87973929 |
| 4 | MP0003283_abnormal_digestive_organ | 3.65835144 |
| 5 | MP0004264_abnormal_extraembryonic_tissu | 3.52409893 |
| 6 | MP0005360_urolithiasis | 3.49512467 |
| 7 | MP0002796_impaired_skin_barrier | 2.87389494 |
| 8 | MP0003436_decreased_susceptibility_to | 2.82517621 |
| 9 | MP0009840_abnormal_foam_cell | 2.69713034 |
| 10 | MP0003195_calcinosis | 2.62462372 |
| 11 | MP0003724_increased_susceptibility_to | 2.53146363 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.50642515 |
| 13 | MP0002254_reproductive_system_inflammat | 2.50302369 |
| 14 | MP0002138_abnormal_hepatobiliary_system | 2.44902775 |
| 15 | MP0003303_peritoneal_inflammation | 2.44071795 |
| 16 | MP0000462_abnormal_digestive_system | 2.33477247 |
| 17 | MP0005058_abnormal_lysosome_morphology | 2.27785422 |
| 18 | MP0002148_abnormal_hypersensitivity_rea | 2.27581911 |
| 19 | MP0009785_altered_susceptibility_to | 2.27248214 |
| 20 | MP0003183_abnormal_peptide_metabolism | 2.19868135 |
| 21 | MP0003705_abnormal_hypodermis_morpholog | 2.17281948 |
| 22 | * MP0002098_abnormal_vibrissa_morphology | 2.13993619 |
| 23 | MP0003866_abnormal_defecation | 2.13410655 |
| 24 | * MP0009643_abnormal_urine_homeostasis | 2.10742289 |
| 25 | MP0002693_abnormal_pancreas_physiology | 2.10425681 |
| 26 | MP0000013_abnormal_adipose_tissue | 2.09455396 |
| 27 | * MP0001765_abnormal_ion_homeostasis | 2.09418766 |
| 28 | MP0005387_immune_system_phenotype | 2.08999425 |
| 29 | MP0001790_abnormal_immune_system | 2.08999425 |
| 30 | MP0006082_CNS_inflammation | 1.99676465 |
| 31 | MP0009780_abnormal_chondrocyte_physiolo | 1.96386278 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.95671793 |
| 33 | * MP0001666_abnormal_nutrient_absorption | 1.95259196 |
| 34 | MP0000579_abnormal_nail_morphology | 1.89487979 |
| 35 | MP0001944_abnormal_pancreas_morphology | 1.88307669 |
| 36 | * MP0005000_abnormal_immune_tolerance | 1.87611257 |
| 37 | * MP0005025_abnormal_response_to | 1.85823273 |
| 38 | * MP0002419_abnormal_innate_immunity | 1.83347967 |
| 39 | MP0001533_abnormal_skeleton_physiology | 1.81068240 |
| 40 | * MP0000678_abnormal_parathyroid_gland | 1.78873227 |
| 41 | MP0005671_abnormal_response_to | 1.78440641 |
| 42 | * MP0004019_abnormal_vitamin_homeostasis | 1.73610173 |
| 43 | MP0005451_abnormal_body_composition | 1.73278890 |
| 44 | MP0000685_abnormal_immune_system | 1.72586481 |
| 45 | MP0003252_abnormal_bile_duct | 1.69340150 |
| 46 | MP0010352_gastrointestinal_tract_polyps | 1.68354158 |
| 47 | MP0005501_abnormal_skin_physiology | 1.67168055 |
| 48 | MP0005220_abnormal_exocrine_pancreas | 1.66521624 |
| 49 | MP0002060_abnormal_skin_morphology | 1.65093441 |
| 50 | MP0010386_abnormal_urinary_bladder | 1.60834744 |
| 51 | MP0000538_abnormal_urinary_bladder | 1.59669996 |
| 52 | MP0002909_abnormal_adrenal_gland | 1.59281959 |
| 53 | * MP0002452_abnormal_antigen_presenting | 1.57652016 |
| 54 | MP0000613_abnormal_salivary_gland | 1.57191063 |
| 55 | MP0001800_abnormal_humoral_immune | 1.56031665 |
| 56 | MP0006054_spinal_hemorrhage | 1.54667040 |
| 57 | * MP0001845_abnormal_inflammatory_respons | 1.53010591 |
| 58 | MP0005166_decreased_susceptibility_to | 1.52716844 |
| 59 | * MP0001216_abnormal_epidermal_layer | 1.51090684 |
| 60 | * MP0002723_abnormal_immune_serum | 1.48865275 |
| 61 | MP0005257_abnormal_intraocular_pressure | 1.48171091 |
| 62 | MP0003941_abnormal_skin_development | 1.45761784 |
| 63 | MP0005275_abnormal_skin_tensile | 1.44080415 |
| 64 | MP0003448_altered_tumor_morphology | 1.41801251 |
| 65 | * MP0002896_abnormal_bone_mineralization | 1.41166889 |
| 66 | MP0005464_abnormal_platelet_physiology | 1.40219169 |
| 67 | MP0009764_decreased_sensitivity_to | 1.39879203 |
| 68 | MP0002998_abnormal_bone_remodeling | 1.37902918 |
| 69 | * MP0005636_abnormal_mineral_homeostasis | 1.37250339 |
| 70 | * MP0003300_gastrointestinal_ulcer | 1.36627391 |
| 71 | MP0005023_abnormal_wound_healing | 1.35697126 |
| 72 | MP0002139_abnormal_hepatobiliary_system | 1.35515468 |
| 73 | MP0002234_abnormal_pharynx_morphology | 1.35451552 |
| 74 | MP0001881_abnormal_mammary_gland | 1.35175755 |
| 75 | MP0000858_altered_metastatic_potential | 1.34465851 |
| 76 | MP0008438_abnormal_cutaneous_collagen | 1.34421734 |
| 77 | MP0001873_stomach_inflammation | 1.32985451 |
| 78 | MP0001958_emphysema | 1.32685547 |
| 79 | MP0005381_digestive/alimentary_phenotyp | 1.31308925 |
| 80 | * MP0001819_abnormal_immune_cell | 1.29603111 |
| 81 | MP0000467_abnormal_esophagus_morphology | 1.29150714 |
| 82 | * MP0002420_abnormal_adaptive_immunity | 1.28461973 |
| 83 | MP0003075_altered_response_to | 1.27600044 |
| 84 | MP0005409_darkened_coat_color | 1.26828834 |
| 85 | MP0005379_endocrine/exocrine_gland_phen | 1.26630723 |
| 86 | MP0003453_abnormal_keratinocyte_physiol | 1.25580864 |
| 87 | MP0000343_altered_response_to | 1.25228315 |
| 88 | MP0008004_abnormal_stomach_pH | 1.24894072 |
| 89 | MP0003566_abnormal_cell_adhesion | 1.24669035 |
| 90 | MP0009379_abnormal_foot_pigmentation | 1.23318747 |
| 91 | MP0003172_abnormal_lysosome_physiology | 1.21508562 |
| 92 | MP0005377_hearing/vestibular/ear_phenot | 1.21168492 |
| 93 | MP0003878_abnormal_ear_physiology | 1.21168492 |
| 94 | * MP0001756_abnormal_urination | 1.20531565 |
| 95 | * MP0010155_abnormal_intestine_physiology | 1.20042631 |
| 96 | * MP0000377_abnormal_hair_follicle | 1.20023729 |
| 97 | * MP0008469_abnormal_protein_level | 1.19991125 |
| 98 | MP0000465_gastrointestinal_hemorrhage | 1.19977055 |
| 99 | MP0000003_abnormal_adipose_tissue | 1.18823865 |
| 100 | MP0010678_abnormal_skin_adnexa | 1.17939474 |
| 101 | MP0000537_abnormal_urethra_morphology | 1.16991775 |
| 102 | MP0000604_amyloidosis | 1.16803440 |
| 103 | MP0008961_abnormal_basal_metabolism | 1.16757049 |
| 104 | MP0000762_abnormal_tongue_morphology | 1.15972589 |
| 105 | MP0004782_abnormal_surfactant_physiolog | 1.15226314 |
| 106 | MP0001664_abnormal_digestion | 1.14904723 |
| 107 | MP0001663_abnormal_digestive_system | 1.14141879 |
| 108 | MP0001270_distended_abdomen | 1.13443107 |
| 109 | MP0003806_abnormal_nucleotide_metabolis | 1.11848516 |
| 110 | MP0000427_abnormal_hair_cycle | 1.10168911 |
| 111 | MP0005085_abnormal_gallbladder_physiolo | 1.09220017 |
| 112 | * MP0002136_abnormal_kidney_physiology | 1.07651206 |
| 113 | * MP0009333_abnormal_splenocyte_physiolog | 1.05562067 |
| 114 | MP0005390_skeleton_phenotype | 1.05229704 |
| 115 | MP0008260_abnormal_autophagy | 1.05108828 |
| 116 | MP0002405_respiratory_system_inflammati | 1.03640852 |
| 117 | * MP0002078_abnormal_glucose_homeostasis | 1.01603221 |
| 118 | MP0003828_pulmonary_edema | 1.01568764 |
| 119 | MP0000516_abnormal_urinary_system | 1.01340619 |
| 120 | MP0005367_renal/urinary_system_phenotyp | 1.01340619 |
| 121 | MP0003045_fibrosis | 1.00914512 |
| 122 | MP0003091_abnormal_cell_migration | 1.00882353 |
| 123 | * MP0000477_abnormal_intestine_morphology | 1.00744962 |
| 124 | MP0005310_abnormal_salivary_gland | 1.00545443 |
| 125 | MP0003279_aneurysm | 1.00370515 |
| 126 | MP0005332_abnormal_amino_acid | 0.98079748 |
| 127 | MP0004381_abnormal_hair_follicle | 0.96484397 |
| 128 | MP0002166_altered_tumor_susceptibility | 0.96144341 |
| 129 | MP0004858_abnormal_nervous_system | 0.95784026 |
| 130 | MP0009384_cardiac_valve_regurgitation | 0.95661861 |
| 131 | * MP0004947_skin_inflammation | 0.94198359 |
| 132 | MP0004510_myositis | 0.93823155 |
| 133 | MP0005164_abnormal_response_to | 0.93203356 |
| 134 | MP0001346_abnormal_lacrimal_gland | 0.92305587 |
| 135 | * MP0000490_abnormal_crypts_of | 0.92117799 |
| 136 | MP0008875_abnormal_xenobiotic_pharmacok | 0.91672365 |
| 137 | MP0001542_abnormal_bone_strength | 0.91373463 |
| 138 | MP0000383_abnormal_hair_follicle | 0.90158348 |
| 139 | MP0010771_integument_phenotype | 0.88221891 |
| 140 | * MP0000716_abnormal_immune_system | 0.87635128 |
| 141 | MP0003763_abnormal_thymus_physiology | 0.87189217 |
| 142 | MP0002928_abnormal_bile_duct | 0.86690297 |
| 143 | MP0005084_abnormal_gallbladder_morpholo | 0.86356657 |
| 144 | MP0005365_abnormal_bile_salt | 0.86338263 |
| 145 | MP0000647_abnormal_sebaceous_gland | 0.85798640 |
| 146 | MP0002009_preneoplasia | 0.84308674 |
| 147 | MP0002006_tumorigenesis | 0.83647843 |
| 148 | MP0000470_abnormal_stomach_morphology | 0.79087924 |
| 149 | * MP0000367_abnormal_coat/_hair | 0.77574245 |
| 150 | * MP0000163_abnormal_cartilage_morphology | 0.76678704 |
| 151 | * MP0003795_abnormal_bone_structure | 0.75296833 |
| 152 | * MP0001191_abnormal_skin_condition | 0.74721017 |
| 153 | MP0005375_adipose_tissue_phenotype | 0.74358324 |
| 154 | MP0009931_abnormal_skin_appearance | 0.74073924 |
| 155 | MP0001348_abnormal_lacrimal_gland | 0.69330411 |
| 156 | MP0005248_abnormal_Harderian_gland | 0.67581134 |
| 157 | MP0000627_abnormal_mammary_gland | 0.66898796 |
| 158 | * MP0003953_abnormal_hormone_level | 0.66300780 |
| 159 | MP0004185_abnormal_adipocyte_glucose | 0.63723683 |
| 160 | MP0003868_abnormal_feces_composition | 0.63511936 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperactive renin-angiotensin system (HP:0000841) | 5.60414811 |
| 2 | Abnormality of chloride homeostasis (HP:0011422) | 4.87480832 |
| 3 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.76868150 |
| 4 | Metabolic alkalosis (HP:0200114) | 4.49446610 |
| 5 | Abnormality of renin-angiotensin system (HP:0000847) | 4.17417771 |
| 6 | Hypoglycemic coma (HP:0001325) | 4.09020315 |
| 7 | Eczematoid dermatitis (HP:0000976) | 4.05978196 |
| 8 | Hypoglycemic seizures (HP:0002173) | 3.95356858 |
| 9 | Hypokalemic alkalosis (HP:0001949) | 3.91754778 |
| 10 | Increased circulating renin level (HP:0000848) | 3.91435676 |
| 11 | Gout (HP:0001997) | 3.89991416 |
| 12 | Hypokalemia (HP:0002900) | 3.82765654 |
| 13 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.74170178 |
| 14 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.74170178 |
| 15 | Abnormality of glycolipid metabolism (HP:0010969) | 3.74170178 |
| 16 | Ketoacidosis (HP:0001993) | 3.71687326 |
| 17 | Abnormality of macrophages (HP:0004311) | 3.64457048 |
| 18 | Generalized aminoaciduria (HP:0002909) | 3.63810988 |
| 19 | Decreased circulating renin level (HP:0003351) | 3.48334567 |
| 20 | Right ventricular cardiomyopathy (HP:0011663) | 3.47471533 |
| 21 | Abnormality of purine metabolism (HP:0004352) | 3.39666931 |
| 22 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.32583376 |
| 23 | Hyperphosphaturia (HP:0003109) | 3.24932539 |
| 24 | Systemic lupus erythematosus (HP:0002725) | 3.19683793 |
| 25 | Recurrent bacterial skin infections (HP:0005406) | 3.19450778 |
| 26 | Abnormal pancreas size (HP:0012094) | 3.15683358 |
| 27 | Hyperaldosteronism (HP:0000859) | 3.15648141 |
| 28 | * Symptomatic seizures (HP:0011145) | 3.08232691 |
| 29 | Hyperglycemia (HP:0003074) | 3.07695445 |
| 30 | Ileus (HP:0002595) | 3.06009071 |
| 31 | Hypomagnesemia (HP:0002917) | 3.03520675 |
| 32 | Abnormality of potassium homeostasis (HP:0011042) | 2.99736749 |
| 33 | Fragile nails (HP:0001808) | 2.98142360 |
| 34 | Abnormality of magnesium homeostasis (HP:0004921) | 2.97313747 |
| 35 | Tetany (HP:0001281) | 2.96981960 |
| 36 | Chronic diarrhea (HP:0002028) | 2.96560081 |
| 37 | Woolly hair (HP:0002224) | 2.95553693 |
| 38 | Abnormality of urine glucose concentration (HP:0011016) | 2.94560051 |
| 39 | Glycosuria (HP:0003076) | 2.94560051 |
| 40 | Recurrent abscess formation (HP:0002722) | 2.93972142 |
| 41 | Orchitis (HP:0100796) | 2.93236772 |
| 42 | Abnormality of renal excretion (HP:0011036) | 2.93157227 |
| 43 | Late onset (HP:0003584) | 2.92901284 |
| 44 | Myositis (HP:0100614) | 2.92718146 |
| 45 | Alkalosis (HP:0001948) | 2.91148667 |
| 46 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.89521322 |
| 47 | Villous atrophy (HP:0011473) | 2.89521322 |
| 48 | Abnormal urine output (HP:0012590) | 2.87117920 |
| 49 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.86821612 |
| 50 | Increased cerebral lipofuscin (HP:0011813) | 2.85630668 |
| 51 | Alopecia of scalp (HP:0002293) | 2.84676303 |
| 52 | Polyuria (HP:0000103) | 2.84586976 |
| 53 | Pili torti (HP:0003777) | 2.84492737 |
| 54 | Petechiae (HP:0000967) | 2.83543333 |
| 55 | Malnutrition (HP:0004395) | 2.83340128 |
| 56 | Abnormal urine phosphate concentration (HP:0012599) | 2.79944260 |
| 57 | Plantar hyperkeratosis (HP:0007556) | 2.78824150 |
| 58 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.76959525 |
| 59 | * Abdominal distention (HP:0003270) | 2.75903139 |
| 60 | Dehydration (HP:0001944) | 2.74065160 |
| 61 | Thick nail (HP:0001805) | 2.73856555 |
| 62 | Abnormality of nail color (HP:0100643) | 2.71548025 |
| 63 | Proximal tubulopathy (HP:0000114) | 2.66875778 |
| 64 | Milia (HP:0001056) | 2.64386937 |
| 65 | Congenital sensorineural hearing impairment (HP:0008527) | 2.63220433 |
| 66 | Increased purine levels (HP:0004368) | 2.61960696 |
| 67 | Hyperuricemia (HP:0002149) | 2.61960696 |
| 68 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.57068505 |
| 69 | Mucopolysacchariduria (HP:0008155) | 2.56541920 |
| 70 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.56541920 |
| 71 | Conjugated hyperbilirubinemia (HP:0002908) | 2.55277095 |
| 72 | Abnormal hemoglobin (HP:0011902) | 2.53496784 |
| 73 | Pustule (HP:0200039) | 2.52680241 |
| 74 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.52475494 |
| 75 | * Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.49991843 |
| 76 | Loss of speech (HP:0002371) | 2.49316043 |
| 77 | Unilateral renal agenesis (HP:0000122) | 2.48279767 |
| 78 | Gingivitis (HP:0000230) | 2.47416941 |
| 79 | Renal salt wasting (HP:0000127) | 2.41306691 |
| 80 | Hydroxyprolinuria (HP:0003080) | 2.39913985 |
| 81 | Abnormality of proline metabolism (HP:0010907) | 2.39913985 |
| 82 | Atrophic scars (HP:0001075) | 2.38463908 |
| 83 | Insulin resistance (HP:0000855) | 2.36911248 |
| 84 | * Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.36524573 |
| 85 | Cheilitis (HP:0100825) | 2.35866101 |
| 86 | Retrobulbar optic neuritis (HP:0100654) | 2.33746138 |
| 87 | Optic neuritis (HP:0100653) | 2.33746138 |
| 88 | Flat acetabular roof (HP:0003180) | 2.33270364 |
| 89 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.30183044 |
| 90 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.30183044 |
| 91 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.30183044 |
| 92 | * Hypophosphatemia (HP:0002148) | 2.28135883 |
| 93 | Vacuolated lymphocytes (HP:0001922) | 2.27316549 |
| 94 | Adrenal overactivity (HP:0002717) | 2.25096287 |
| 95 | Osteolytic defects of the hand bones (HP:0009699) | 2.24931857 |
| 96 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.24931857 |
| 97 | Increased IgE level (HP:0003212) | 2.23038118 |
| 98 | Abnormal drinking behavior (HP:0030082) | 2.21907704 |
| 99 | Polydipsia (HP:0001959) | 2.21907704 |
| 100 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.21608410 |
| 101 | Cervical subluxation (HP:0003308) | 2.20939909 |
| 102 | Hypotrichosis (HP:0001006) | 2.20802362 |
| 103 | Onycholysis (HP:0001806) | 2.20405503 |
| 104 | Abnormal blistering of the skin (HP:0008066) | 2.18431852 |
| 105 | Hypercalciuria (HP:0002150) | 2.18224195 |
| 106 | Stomatitis (HP:0010280) | 2.17850623 |
| 107 | Abnormal hair laboratory examination (HP:0003328) | 2.17446131 |
| 108 | Neonatal short-limb short stature (HP:0008921) | 2.15451703 |
| 109 | Vasculitis (HP:0002633) | 2.14653905 |
| 110 | Interstitial pulmonary disease (HP:0006530) | 2.13564009 |
| 111 | Pulmonary infiltrates (HP:0002113) | 2.10626930 |
| 112 | Abnormality of the gastric mucosa (HP:0004295) | 2.10361672 |
| 113 | Urticaria (HP:0001025) | 2.10134726 |
| 114 | Dysostosis multiplex (HP:0000943) | 2.09281193 |
| 115 | Spontaneous hematomas (HP:0007420) | 2.07876336 |
| 116 | Hemoptysis (HP:0002105) | 2.07815287 |
| 117 | Abnormal biliary tract morphology (HP:0012440) | 2.06446627 |
| 118 | Ventricular fibrillation (HP:0001663) | 2.03583967 |
| 119 | Premature rupture of membranes (HP:0001788) | 2.02979517 |
| 120 | Hyperphosphatemia (HP:0002905) | 2.02426484 |
| 121 | Purpura (HP:0000979) | 2.02270494 |
| 122 | Vertebral compression fractures (HP:0002953) | 2.01751377 |
| 123 | Autoimmune thrombocytopenia (HP:0001973) | 2.01733605 |
| 124 | Recurrent skin infections (HP:0001581) | 2.01132779 |
| 125 | Emphysema (HP:0002097) | 2.01121981 |
| 126 | Nail dystrophy (HP:0008404) | 2.00895661 |
| 127 | Ketosis (HP:0001946) | 2.00869531 |
| 128 | Thoracolumbar scoliosis (HP:0002944) | 2.00812178 |
| 129 | Palmoplantar hyperkeratosis (HP:0000972) | 2.00771822 |
| 130 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.00320003 |
| 131 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.00320003 |
| 132 | Osteomalacia (HP:0002749) | 2.00198878 |
| 133 | Recurrent fungal infections (HP:0002841) | 2.00189403 |
| 134 | Peritonitis (HP:0002586) | 2.00067003 |
| 135 | Axonal loss (HP:0003447) | 1.99644553 |
| 136 | Amyloidosis (HP:0011034) | 1.98004081 |
| 137 | Curly hair (HP:0002212) | 1.95796636 |
| 138 | Fragile skin (HP:0001030) | 1.94365476 |
| 139 | Abnormal tarsal ossification (HP:0008369) | 1.94157601 |
| 140 | * Hyperparathyroidism (HP:0000843) | 1.93360402 |
| 141 | Abnormality of nucleobase metabolism (HP:0010932) | 1.92607115 |
| 142 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.91251721 |
| 143 | Ridged nail (HP:0001807) | 1.90563900 |
| 144 | Gastrointestinal infarctions (HP:0005244) | 1.90365181 |
| 145 | Hypergammaglobulinemia (HP:0010702) | 1.90292382 |
| 146 | Obstructive lung disease (HP:0006536) | 1.89505457 |
| 147 | Chronic obstructive pulmonary disease (HP:0006510) | 1.89505457 |
| 148 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.89443855 |
| 149 | Exocrine pancreatic insufficiency (HP:0001738) | 1.89295249 |
| 150 | Mediastinal lymphadenopathy (HP:0100721) | 1.88656275 |
| 151 | Hypotension (HP:0002615) | 1.88137935 |
| 152 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.87020362 |
| 153 | * Bone pain (HP:0002653) | 1.86606310 |
| 154 | Hyperglycinuria (HP:0003108) | 1.86148462 |
| 155 | Spondylolisthesis (HP:0003302) | 1.86072432 |
| 156 | Palmar hyperkeratosis (HP:0010765) | 1.85086529 |
| 157 | * Nephrolithiasis (HP:0000787) | 1.84684425 |
| 158 | Keratoconjunctivitis sicca (HP:0001097) | 1.83490528 |
| 159 | Myocardial infarction (HP:0001658) | 1.80706323 |
| 160 | Follicular hyperkeratosis (HP:0007502) | 1.79189259 |
| 161 | Gingival bleeding (HP:0000225) | 1.79059203 |
| 162 | Skin ulcer (HP:0200042) | 1.76434226 |
| 163 | Increased serum ferritin (HP:0003281) | 1.75492562 |
| 164 | Gastrointestinal stroma tumor (HP:0100723) | 1.75031940 |
| 165 | Nephritis (HP:0000123) | 1.68489374 |
| 166 | Hematochezia (HP:0002573) | 1.67829641 |
| 167 | Glomerulonephritis (HP:0000099) | 1.67789833 |
| 168 | Epistaxis (HP:0000421) | 1.66694604 |
| 169 | Gangrene (HP:0100758) | 1.66398685 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 4.20873490 |
| 2 | ERN1 | 3.94551209 |
| 3 | WNK4 | 3.91721683 |
| 4 | MST1R | 3.69432052 |
| 5 | FRK | 3.51687327 |
| 6 | PASK | 3.13783196 |
| 7 | MAP3K2 | 2.87325743 |
| 8 | MAPK15 | 2.47754080 |
| 9 | RIPK4 | 2.41077217 |
| 10 | WNK3 | 2.32179869 |
| 11 | ACVR1B | 2.25094226 |
| 12 | MST4 | 2.05904150 |
| 13 | TYK2 | 2.05092165 |
| 14 | HIPK2 | 2.03230744 |
| 15 | EPHA3 | 1.93632861 |
| 16 | MAP2K2 | 1.89552428 |
| 17 | MET | 1.87428174 |
| 18 | PTK6 | 1.87112071 |
| 19 | IRAK3 | 1.85586520 |
| 20 | EPHB2 | 1.85107858 |
| 21 | PRPF4B | 1.84579087 |
| 22 | TAOK3 | 1.77975273 |
| 23 | MAP4K1 | 1.77569623 |
| 24 | PIK3CA | 1.69669192 |
| 25 | MAP3K13 | 1.66066452 |
| 26 | BLK | 1.64744595 |
| 27 | CDK12 | 1.62236304 |
| 28 | IRAK4 | 1.60419599 |
| 29 | PRKG2 | 1.58817036 |
| 30 | LMTK2 | 1.53949625 |
| 31 | MAP3K3 | 1.53007239 |
| 32 | RIPK1 | 1.49994588 |
| 33 | EPHB1 | 1.49914586 |
| 34 | PRKD3 | 1.46901503 |
| 35 | FER | 1.46220072 |
| 36 | NME1 | 1.43998541 |
| 37 | MAP3K1 | 1.41334465 |
| 38 | OXSR1 | 1.41187228 |
| 39 | EPHA2 | 1.40387560 |
| 40 | PTK2 | 1.40351921 |
| 41 | FLT3 | 1.34148078 |
| 42 | PDGFRA | 1.32146677 |
| 43 | IKBKB | 1.27540952 |
| 44 | TAOK1 | 1.27170272 |
| 45 | STK24 | 1.23456173 |
| 46 | IKBKE | 1.22836897 |
| 47 | TXK | 1.21766351 |
| 48 | NUAK1 | 1.18504434 |
| 49 | LATS1 | 1.16007353 |
| 50 | FGFR4 | 1.14507245 |
| 51 | PIK3CG | 1.12210563 |
| 52 | MYLK | 1.11896376 |
| 53 | TAOK2 | 1.09253947 |
| 54 | WNK1 | 1.08998195 |
| 55 | SIK3 | 1.08309540 |
| 56 | TRIB3 | 1.06699811 |
| 57 | DYRK1B | 1.06113279 |
| 58 | PIM2 | 1.04761334 |
| 59 | TESK2 | 1.03915186 |
| 60 | DDR2 | 1.00795382 |
| 61 | IRAK1 | 0.98923988 |
| 62 | MAP2K3 | 0.96612322 |
| 63 | STK39 | 0.95681256 |
| 64 | GRK7 | 0.95217571 |
| 65 | CSF1R | 0.94911106 |
| 66 | FGFR3 | 0.94331733 |
| 67 | MAP3K11 | 0.93888764 |
| 68 | BMPR2 | 0.93030391 |
| 69 | FGR | 0.89727283 |
| 70 | NTRK1 | 0.89334145 |
| 71 | MATK | 0.86051081 |
| 72 | KSR2 | 0.84498276 |
| 73 | SMG1 | 0.82566477 |
| 74 | KIT | 0.81829270 |
| 75 | RPS6KA2 | 0.80461037 |
| 76 | GRK6 | 0.78894221 |
| 77 | SIK1 | 0.78824199 |
| 78 | MAPKAPK3 | 0.78647949 |
| 79 | CDC42BPA | 0.78332182 |
| 80 | PDPK1 | 0.77460271 |
| 81 | MAP3K6 | 0.76486396 |
| 82 | MAP3K12 | 0.75976195 |
| 83 | STK38L | 0.75856576 |
| 84 | BTK | 0.75441071 |
| 85 | ABL2 | 0.75326924 |
| 86 | MAP2K6 | 0.75264076 |
| 87 | GRK1 | 0.73427121 |
| 88 | CHUK | 0.72818722 |
| 89 | HCK | 0.70332281 |
| 90 | SYK | 0.70241176 |
| 91 | NLK | 0.67728432 |
| 92 | ARAF | 0.67301587 |
| 93 | JAK3 | 0.65433948 |
| 94 | IRAK2 | 0.62118143 |
| 95 | JAK2 | 0.62022090 |
| 96 | NEK9 | 0.61715510 |
| 97 | PRKCI | 0.61573034 |
| 98 | LYN | 0.61360003 |
| 99 | PRKD2 | 0.60962454 |
| 100 | TESK1 | 0.57792357 |
| 101 | LRRK2 | 0.57599153 |
| 102 | TGFBR2 | 0.55962793 |
| 103 | ITK | 0.54853321 |
| 104 | SCYL2 | 0.54604703 |
| 105 | MAPK7 | 0.54285258 |
| 106 | RPS6KC1 | 0.53542002 |
| 107 | RPS6KL1 | 0.53542002 |
| 108 | GSK3A | 0.52591991 |
| 109 | ADRBK2 | 0.52458214 |
| 110 | BCKDK | 0.52093886 |
| 111 | LCK | 0.51861479 |
| 112 | PDK1 | 0.46259379 |
| 113 | MAP3K7 | 0.45395556 |
| 114 | PDK2 | 0.44426474 |
| 115 | PRKAA2 | 0.43036361 |
| 116 | PAK3 | 0.42981976 |
| 117 | PRKAA1 | 0.40832311 |
| 118 | RET | 0.39534905 |
| 119 | CSK | 0.39027597 |
| 120 | MAP2K1 | 0.38555120 |
| 121 | ERBB2 | 0.38252712 |
| 122 | MAP3K10 | 0.37221335 |
| 123 | PKN2 | 0.36842386 |
| 124 | NME2 | 0.36460961 |
| 125 | CDK9 | 0.35948952 |
| 126 | PDGFRB | 0.35410569 |
| 127 | MAPK11 | 0.34343354 |
| 128 | TBK1 | 0.33576765 |
| 129 | AKT3 | 0.31514531 |
| 130 | BMX | 0.31384918 |
| 131 | GRK5 | 0.30895944 |
| 132 | IGF1R | 0.30632824 |
| 133 | CSNK1A1 | 0.30626063 |
| 134 | BCR | 0.30614972 |
| 135 | JAK1 | 0.30195385 |
| 136 | MAP3K14 | 0.30108339 |
| 137 | STK10 | 0.29790928 |
| 138 | PRKCH | 0.29515170 |
| 139 | PAK4 | 0.28678654 |
| 140 | PRKCD | 0.28261353 |
| 141 | TRPM7 | 0.27211343 |
| 142 | MAPKAPK2 | 0.26556062 |
| 143 | ZAP70 | 0.26413989 |
| 144 | PRKCE | 0.25596816 |
| 145 | BMPR1B | 0.23249311 |
| 146 | PRKD1 | 0.21265999 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 7.11198631 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 4.42256232 |
| 3 | Protein export_Homo sapiens_hsa03060 | 2.55694816 |
| 4 | Galactose metabolism_Homo sapiens_hsa00052 | 2.42664058 |
| 5 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.32846964 |
| 6 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.31930552 |
| 7 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.27769696 |
| 8 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.23954493 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.16902186 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.06095140 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.03334626 |
| 12 | Asthma_Homo sapiens_hsa05310 | 2.02408599 |
| 13 | * Mineral absorption_Homo sapiens_hsa04978 | 1.98021672 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.94226369 |
| 15 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.92090826 |
| 16 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.87277002 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.85960145 |
| 18 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.80425003 |
| 19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.78879492 |
| 20 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.73059961 |
| 21 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.71809101 |
| 22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.69930076 |
| 23 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.65310137 |
| 24 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.64894352 |
| 25 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.64784072 |
| 26 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.63400648 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.61128110 |
| 28 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.58464759 |
| 29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.58381080 |
| 30 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.53819249 |
| 31 | * Tuberculosis_Homo sapiens_hsa05152 | 1.53395759 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.49451463 |
| 33 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.48800638 |
| 34 | Insulin secretion_Homo sapiens_hsa04911 | 1.45301206 |
| 35 | Other glycan degradation_Homo sapiens_hsa00511 | 1.44411536 |
| 36 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.39405101 |
| 37 | Histidine metabolism_Homo sapiens_hsa00340 | 1.38659155 |
| 38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.36637871 |
| 39 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.35224897 |
| 40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.33461228 |
| 41 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.28206632 |
| 42 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.26061770 |
| 43 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.25780599 |
| 44 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.23048799 |
| 45 | Malaria_Homo sapiens_hsa05144 | 1.22165503 |
| 46 | Influenza A_Homo sapiens_hsa05164 | 1.21933857 |
| 47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.19368486 |
| 48 | Bile secretion_Homo sapiens_hsa04976 | 1.18783656 |
| 49 | Phagosome_Homo sapiens_hsa04145 | 1.15931173 |
| 50 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.15381392 |
| 51 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.10862230 |
| 52 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.10675001 |
| 53 | Bladder cancer_Homo sapiens_hsa05219 | 1.09441118 |
| 54 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.07431912 |
| 55 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.06878570 |
| 56 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.06835217 |
| 57 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.05098469 |
| 58 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.02857699 |
| 59 | Salmonella infection_Homo sapiens_hsa05132 | 1.02576257 |
| 60 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.00781072 |
| 61 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.00172866 |
| 62 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.99095847 |
| 63 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.97506826 |
| 64 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.97037819 |
| 65 | Viral myocarditis_Homo sapiens_hsa05416 | 0.96304592 |
| 66 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.96095968 |
| 67 | ABC transporters_Homo sapiens_hsa02010 | 0.95536942 |
| 68 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.94152449 |
| 69 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.92257119 |
| 70 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.90392823 |
| 71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.89757190 |
| 72 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.88941671 |
| 73 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.87254855 |
| 74 | Shigellosis_Homo sapiens_hsa05131 | 0.86389105 |
| 75 | Thyroid cancer_Homo sapiens_hsa05216 | 0.83819645 |
| 76 | Measles_Homo sapiens_hsa05162 | 0.83725411 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.81283717 |
| 78 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.80731461 |
| 79 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.78394465 |
| 80 | Lysosome_Homo sapiens_hsa04142 | 0.77811723 |
| 81 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.75463453 |
| 82 | Apoptosis_Homo sapiens_hsa04210 | 0.74941148 |
| 83 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.74728480 |
| 84 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.71730937 |
| 85 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.71292824 |
| 86 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.70391341 |
| 87 | Platelet activation_Homo sapiens_hsa04611 | 0.70230044 |
| 88 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.68287249 |
| 89 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.67530717 |
| 90 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.65950766 |
| 91 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65938767 |
| 92 | Hepatitis B_Homo sapiens_hsa05161 | 0.65166682 |
| 93 | Lysine degradation_Homo sapiens_hsa00310 | 0.62879877 |
| 94 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.62104763 |
| 95 | * Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.59104407 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | 0.57490314 |
| 97 | Tight junction_Homo sapiens_hsa04530 | 0.54973930 |
| 98 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.54077577 |
| 99 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.53903709 |
| 100 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53576413 |
| 101 | Endocytosis_Homo sapiens_hsa04144 | 0.52587305 |
| 102 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50693229 |
| 103 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49397639 |
| 104 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.46241196 |
| 105 | Peroxisome_Homo sapiens_hsa04146 | 0.46056984 |
| 106 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.45967020 |
| 107 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.45865718 |
| 108 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.43765423 |
| 109 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.43659075 |
| 110 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.41901847 |
| 111 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.41835831 |
| 112 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.40827494 |
| 113 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.40650959 |
| 114 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.40590348 |
| 115 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.40425035 |
| 116 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.39318533 |
| 117 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.38746694 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37293483 |
| 119 | Adherens junction_Homo sapiens_hsa04520 | 0.37063985 |
| 120 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.36416925 |
| 121 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.33932770 |
| 122 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33727029 |
| 123 | Ribosome_Homo sapiens_hsa03010 | 0.32669802 |
| 124 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.32161567 |
| 125 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.30650976 |
| 126 | Legionellosis_Homo sapiens_hsa05134 | 0.28626668 |
| 127 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.28505739 |
| 128 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.26123135 |
| 129 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.25748233 |
| 130 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.23810347 |
| 131 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.22967881 |
| 132 | Retinol metabolism_Homo sapiens_hsa00830 | 0.22698466 |
| 133 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.21763898 |
| 134 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.21149026 |
| 135 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.20933858 |
| 136 | Cocaine addiction_Homo sapiens_hsa05030 | 0.20704490 |
| 137 | Metabolic pathways_Homo sapiens_hsa01100 | 0.20089386 |
| 138 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.19448769 |
| 139 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.18728532 |
| 140 | Amoebiasis_Homo sapiens_hsa05146 | 0.16414556 |
| 141 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.15926215 |
| 142 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.15723210 |
| 143 | Circadian rhythm_Homo sapiens_hsa04710 | 0.14355319 |
| 144 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.14002482 |
| 145 | Pertussis_Homo sapiens_hsa05133 | 0.13907939 |
| 146 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.12752995 |
| 147 | Prostate cancer_Homo sapiens_hsa05215 | 0.12687702 |
| 148 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.12411433 |
| 149 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.12317749 |
| 150 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.12249285 |
| 151 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.11904643 |
| 152 | Endometrial cancer_Homo sapiens_hsa05213 | 0.11803664 |

